Kala Bio Faces Diminishing Options After Eye Drug Failure

 
• By Andrew McConaghie
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business